These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 18946746)
1. Current topics and perspectives in the treatment of endocrine-related cancers. Iwase H Int J Clin Oncol; 2008 Oct; 13(5):377-9. PubMed ID: 18946746 [No Abstract] [Full Text] [Related]
2. Special issue on steroids and cancer. Preface. Geisler J; Sasano H J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):67. PubMed ID: 22732368 [No Abstract] [Full Text] [Related]
4. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins. Katsuki Y; Shibutani Y; Aoki D; Nozawa S Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742 [TBL] [Abstract][Full Text] [Related]
5. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer. Bodmer A; Castiglione-Gertsch M Eur J Cancer; 2011 Sep; 47 Suppl 3():S28-37. PubMed ID: 21943985 [No Abstract] [Full Text] [Related]
6. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer. Nicholson RI; Walker KJ; Davies P Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778 [No Abstract] [Full Text] [Related]
7. Molecular mechanisms of endocrine resistance and their implication in the therapy of breast cancer. Zilli M; Grassadonia A; Tinari N; Di Giacobbe A; Gildetti S; Giampietro J; Natoli C; Iacobelli S; Biochim Biophys Acta; 2009 Jan; 1795(1):62-81. PubMed ID: 18804516 [TBL] [Abstract][Full Text] [Related]
9. Information Concerning Endocrine Therapy and Adherence of Patients with Breast and Prostate Cancer. Linke B; Liebl P; Marten D; Stoll C; Jung B; Wuensch P; Huebner J Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):482-3. PubMed ID: 25869258 [No Abstract] [Full Text] [Related]
10. Current research topics in endocrine therapy for breast cancer. Yamashita H Int J Clin Oncol; 2008 Oct; 13(5):380-3. PubMed ID: 18946747 [TBL] [Abstract][Full Text] [Related]
11. [Action of SERM and SAS (tibolone) on breast tissue]. Gompel A; Jacob D; de Chambine S; Mimoun M; Decroix Y; Rostene W; Poitout P Contracept Fertil Sex; 1999 May; 27(5):368-75. PubMed ID: 10401183 [TBL] [Abstract][Full Text] [Related]
12. [Hormone therapy of endometrial carcinoma]. Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016 [TBL] [Abstract][Full Text] [Related]
13. [Mechanism and side effect of endocrine therapy]. Tsuda M; Ishiguro H; Saji S Nihon Rinsho; 2015 Feb; 73 Suppl 2():291-7. PubMed ID: 25831770 [No Abstract] [Full Text] [Related]
14. [Adjuvant cancer therapy]. Heinrich B MMW Fortschr Med; 2010 Oct; 152(41):36. PubMed ID: 21090374 [No Abstract] [Full Text] [Related]
15. Searching for the ideal SERM. Poletti A Pharmacol Res; 1999 May; 39(5):333. PubMed ID: 10328989 [No Abstract] [Full Text] [Related]
16. [Tamoxifen: modern drug therapy of estrogen-dependent breast tumors]. Jovanović-Mićić D; Beleslin DB; Nikolić SS Med Pregl; 1996; 49(7-8):287-90. PubMed ID: 8926945 [TBL] [Abstract][Full Text] [Related]
18. [Strategy of drug development for hormone-dependent tumor]. Kudoh M Gan To Kagaku Ryoho; 1996 May; 23(6):668-72. PubMed ID: 8645015 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic targeting in breast cancer]. Penault-Llorca F Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259 [No Abstract] [Full Text] [Related]
20. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]